- 1. (-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic Acid
- [A hydrazine derivative of dopa. Carbidopa is a peripheral dopa decarboxylase inhibitor that is used as an adjunct to levodopa administration to prevent peripheral biosynthesis of levodopa to dopamine, thereby reducing peripheral side effects. Carbidopa does not penetrate the blood brain barrier so that levodopa, after it reaches the brain, can be metabolized to dopamine by dopa decarboxylase where it exerts its effect on dopamine receptors. ( NCI )] (UMLS (NCI) C0006982) =Organic Chemical; Pharmacologic Substance =[CN500] ANTIPARKINSON AGENTS;
hydrazine;
3-Hydroxy-alpha-methyl-L-tyrosine;
=CARBIDOPA 25 MG;
CARBIDOPA 50 MG;
CARBIDOPA 10 MG;
Carbidopa 12.5 MG / entacapone 200 MG / Levodopa 50 MG Oral Tablet;
CARBIDOPA 37.5 MG;
| - 51. laboratory facility
- [ ] (UMLS (CSP) C0598008) =Manufactured Object ;
|
- 2. (Laparoscopic) adjustment of size of adjustable gastric restrictive device
- [ ] (UMLS (ICD9CM) C1456111) ADJUST GAST RESTRICT DEV;
=Therapeutic or Preventive Procedure | - 52. laboratory infection
- [Accidentally acquired infection in laboratory workers. ( MSH )] (UMLS (CSP) C0022882) =Disease or Syndrome ;
=infection;
occupational disease |
- 3. 29-L-Argininamide-30-de-L-glutamine-31-de-L-glutamine-32-deglycine-33-de-L-glutamic acid-34-de-L-serine-35-de-L-asparagine-36-de-L-glutamine-37-de-L-glutamic acid-38-de-L-arginine-39-deglycine-40-de-L-alanine-41-de-L-arginine-42-de-L-alanine-43-de-L-argin
- [The acetate salt form of sermorelin, a synthetic, amidated 29-amino acid peptide that corresponds to the amino-terminal segment of the naturally occurring human growth hormone-releasing hormone (GHRH). Sermorelin acetate directly stimulates the pituitary gland, resulting in release of growth hormone leading to increased plasma growth hormone, which is responsible for many biological processes and counteracts growth hormone deficiency. ( NCI )] (UMLS (NCI) C0162725) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=GHRH;
=SERMORELIN ACETATE 50 MCG;
SERMORELIN ACETATE 1 MG;
SERMORELIN ACETATE 0.5 MG | - 53. Laboratory Management
- (UMLS (HL7) C1552394) =Intellectual Product =Specialist/Technologist, Pathology;
|
- 4. L-Asnase
- (UMLS (NCI) C1510952) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme
| - 54. Laboratory Management, Diplomate
- (UMLS (HL7) C1552395) =Intellectual Product =Specialist/Technologist, Pathology;
|
- 5. L1 Adult Acute Lymphoblastic Leukemia
- (UMLS (NCI) C0279589) =Neoplastic Process
| - 55. laboratory mouse
- [mouse that has been bred or acquired for the purpose of being a research subject in a facility where scientific research and experiments are conducted. ( CSP )] (UMLS (CSP) C0025929) =Mammal ;
=Mammals, Rodents;
=hairless mouse;
athymic mouse;
SCID mouse;
NOD;
albino mouse;
|
- 6. LA
- [A country in Southeastern Asia, northeast of Thailand, west of Vietnam. (NCI) ( NCI )] (UMLS (NCI) C0023034) =Geographic Area ◊ [A state in the southern midwest United States. Its capital is Baton Rouge. ( NCI )] (UMLS (NCI) C0024024) Geographic Area
| - 56. Laboratory order message
- (UMLS (HL7) C1548049) =Idea or Concept =Message type;
|
- 7. La Crosse virus
- [A serotype of the species California encephalitis virus (ENCEPHALITIS VIRUS, CALIFORNIA), in the genus ORTHOBUNYAVIRUS, causing human MENINGOENCEPHALITIS. This is the agent most responsible for California encephalitis (ENCEPHALITIS, CALIFORNIA), the most prevalent mosquito-borne disease recognized in the United States. ( MSH )] (UMLS (CSP) C0022858) =Virus ;
| - 57. Laboratory Procedure
- [A medical procedure that involves testing a sample of blood, urine, or other substance from the body. Tests can help determine a diagnosis, plan treatment, check to see if treatment is working, or monitor the disease over time. ( NCI )] (UMLS (NCI) C0022885) =Laboratory Procedure ;
|
- 8. La element
- [rare metallic element, symbol La, atomic number 57. ( CSP )] (UMLS (CSP) C0023031) =Element, Ion, or Isotope =Metals, Rare Earth;
| - 58. laboratory rabbit
- [rabbit that has been bred or acquired for the purpose of being a research subject in a facility where scientific research and experiments are conducted. ( CSP )] (UMLS (CSP) C0178727) =Mammal ;
=Lagomorpha;
|
- 9. La Jolla Band of Luiseno Mission Indians of the La
- (UMLS (HL7) C1554349) =Population Group =NativeEntityContiguous;
| - 59. laboratory rat
- [rat that has been bred or acquired for the purpose of being a research subject in a facility where scientific research and experiments are conducted. ( CSP )] (UMLS (CSP) C0086893) =Mammal ;
=Mammals, Rodents;
=spontaneous hypertensive rat;
albino rat |
- 10. La Posta Band of Diegueno Mission Indians of the L
- (UMLS (HL7) C1554350) =Population Group =NativeEntityContiguous;
| - 60. laboratory study
- [Research done in a laboratory. These studies may use test tubes or animals to find out if a drug, procedure, or treatment is likely to be useful. Laboratory studies take place before any testing is done in humans. ( NCI )] (UMLS (NCI) C0681827) =Laboratory Procedure ;
|
- 11. La Raza
- (UMLS (HL7) C1553369) =Population Group =Mexican;
| - 61. labored breathing
- [ ] (UMLS (CSP) C0553668) =Sign or Symptom
|
- 12. Lab
- [A workplace for the conduct of scientific research. ( NCI )] (UMLS (NCI) C0022877) =Manufactured Object; Organization
| - 62. LABYRINTH FISTULA COMB
- [ ] (UMLS (ICD9CM) C0155513) =Disease or Syndrome; Anatomical Abnormality
|
- 13. Lab
- [The Labrador Retriever is a solid, muscular dog, with a short, hard, water-resistant double coat that does not have any waves. It comes in solid black, yellow, or chocolate. There is also said to be a rare silver or gray color. The medium-sized ears are pendant. The webbed feet aid in swimming. Height: 21-24 inches (53-61 cm.) Weight: 55-75 pounds (25-34kg.) ( NCI )] (UMLS (NCI) C0324431) =Mammal
| - 63. labyrinthectomy
- [total or partial excision of the internal labyrinth of the ear. ( CSP )] (UMLS (CSP) C0198281) =Therapeutic or Preventive Procedure =ear surgery;
|
- 14. Lab Alert
- [Proposed therapy may be inappropriate or contraindicated due to recent lab test results ( HL7V3.0 )] (UMLS (HL7) C1553536) =Intellectual Product =Observation Alert;
| - 64. LABYRINTHINE DYSFUNC NEC
- [ ] (UMLS (ICD9CM) C0155521) =Disease or Syndrome
|
- 15. Lab Findings
- [The result of a lab test to measure an attribute or to determine the presence, absence or degree of a condition. ( NCI )] (UMLS (NCI) C0237076) =Laboratory or Test Result ;
| - 65. LABYRINTHINE DYSFUNC NOS
- [ ] (UMLS (ICD9CM) C0155514) =Disease or Syndrome ;
|
- 16. Lab Tech
- [A technically trained person who performs laboratory activities and provides laboratory analysis according to laboratory policies, procedures and protocols. ( NCI )] (UMLS (NCI) C1270980) Laboratory Technologist;
=Professional or Occupational Group | - 66. Labyrinthine fistula
- [ ] (UMLS (ICD9CM) C0155509) =Disease or Syndrome; Anatomical Abnormality
|
- 17. lab test category
- [ Definition: ( HL7V3.0 )] (UMLS (HL7) C1699174) =Intellectual Product =ActCode;
| - 67. labyrinthine fluid
- [Fluids found within the osseous labyrinth (PERILYMPH) and the membranous labyrinth (ENDOLYMPH) of the inner ear. (From Gray's Anatomy, 30th American ed, p1328, 1332) ( MSH )] (UMLS (CSP) C0022892) =Body Substance ;
|
- 18. Lab to obtain specimen from patient
- (UMLS (HL7) C1546521) =Intellectual Product =Specimen Action Code;
| - 68. labyrinthine membrane
- [system of communicating epithelial sacs and ducts lodged within the osseous labyrinth but separated from the major portion of the bony labyrinth by the perilymphatic space; contains the endolymph. ( CSP )] (UMLS (CSP) C0458700) =Body Part, Organ, or Organ Component =Inner Ear;
|
- 19. Label
- [A brief description given for purposes of identification; an identifying or descriptive marker that is attached to an object. ( NCI )] (UMLS (NCI) C0181496) =Manufactured Object
| - 69. Labyrinthitis
- [Inflammation of the inner ear (LABYRINTH). ( MSH )] (UMLS (ICD9CM) C0022893) =Disease or Syndrome ;
=Labyrinth Diseases;
|
- 20. Labeling
- (UMLS (HL7) C1548779) =Qualitative Concept =Specimen Reject Reason;
| - 70. LAC CANALICULI PROBE
- [ ] (UMLS (ICD9CM) C0197185) =Therapeutic or Preventive Procedure
|
- 21. LABETALOL
- [A third generation selective alpha-1-adrenergic antagonist and non-selective beta-adrenergic antagonist with vasodilatory and antihypertensive properties. Labetalol competitively binds to alpha-1-adrenergic receptors in vascular smooth muscle, thereby inhibiting the adrenergic stimulation of endothelial cell function and vasoconstriction in peripheral blood vessels. This agent also binds to beta-receptors in the bronchial and vascular smooth muscle, resulting in a decrease in adrenergic stimulation. The result is a decrease in resting and exercise heart rates, cardiac output, and in both systolic and diastolic blood pressure, thereby resulting in vasodilation, and negative chronotropic and inotropic cardiac effects. ( NCI )] (UMLS (NCI) C0022860) =Organic Chemical; Pharmacologic Substance =Ethanolamines;
[CV100] BETA-BLOCKERS/RELATED =Labetalol Hydrochloride;
| - 71. Lac Courte Oreilles Band of Lake Superior Chippewa
- (UMLS (HL7) C1554351) =Population Group =NativeEntityContiguous;
|
- 22. Labetalol Hydrochloride
- [The hydrochloride form of labetalol, a third generation selective alpha-1-adrenergic antagonist and non-selective beta-adrenergic antagonist with vasodilatory and antihypertensive properties. Labetalol competitively binds to alpha-1-adrenergic receptors in vascular smooth muscle, thereby inhibiting the adrenergic stimulation of endothelial cell function and vasoconstriction in peripheral blood vessels. This agent also binds to beta-receptors in the bronchial and vascular smooth muscle, resulting in a decrease in adrenergic stimulation. The result is a decrease in resting and exercise heart rates, cardiac output, and in both systolic and diastolic blood pressure, thereby resulting in vasodilation, and negative chronotropic and inotropic cardiac effects. ( NCI )] (UMLS (NCI) C0699440) =Organic Chemical; Pharmacologic Substance =LABETALOL;
=LABETALOL HYDROCHLORIDE 100 MG;
LABETALOL HYDROCHLORIDE 200 MG;
LABETALOL HYDROCHLORIDE 300 MG;
LABETALOL HYDROCHLORIDE 5 MG/ML;
| - 72. Lac du Flambeau Band of Lake Superior Chippewa Ind
- (UMLS (HL7) C1554352) =Population Group =NativeEntityContiguous;
|
- 23. Labia
- (UMLS (HL7) C0227759) =Body Part, Organ, or Organ Component =Body Part;
| - 73. LAC EYELID INV LACRM PAS
- [ ] (UMLS (ICD9CM) C0160462) =Injury or Poisoning
|
- 24. Labia Majora
- (UMLS (HL7) C0227760) =Body Part, Organ, or Organ Component =Body Part;
| - 74. LAC EYELID SKN/PERIOCULR
- [ ] (UMLS (ICD9CM) C0160460) =Injury or Poisoning
|
- 25. Labia Minora
- (UMLS (HL7) C0227766) =Body Part, Organ, or Organ Component =Body Part;
| - 75. lac operon
- [prokaryotic genetic unit consisting of three structural genes, an operator and a regulatory gene; the regulatory gene controls the synthesis of the three structural genes: beta-galactosidase and beta-galactoside permease (involved with the metabolism of lactose), and beta-thiogalactoside acetyltransferase. ( CSP )] (UMLS (CSP) C0022895) =Gene or Genome ;
=operon;
|
- 26. Labial frenectomy
- (UMLS (ICD9CM) C0191994) =Therapeutic or Preventive Procedure
| - 76. LAC PASSAGE MANIP NEC
- [ ] (UMLS (ICD9CM) C0176182) =Therapeutic or Preventive Procedure
|
- 27. LABIAL FRENOTOMY
- (UMLS (ICD9CM) C0191966) =Therapeutic or Preventive Procedure
| - 77. LAC PUNCTUM OBLITERATION
- [ ] (UMLS (ICD9CM) C0197346) =Therapeutic or Preventive Procedure
|
- 28. Labial Mucosa
- [The inner lining of the lips. ( NCI )] (UMLS (NCI) C0226927) =Body Part, Organ, or Organ Component
| - 78. Lac Vieux Desert Band of Lake Superior Chippewa In
- (UMLS (HL7) C1554353) =Population Group =NativeEntityContiguous;
|
- 29. Labial Salivary Gland
- (UMLS (NCI) C0930554) =Body Part, Organ, or Organ Component
| - 79. laccase
- [A copper-containing oxidoreductase enzyme that catalyzes the oxidation of 4-benzenediol to 4-benzosemiquinone. It also has activity towards a variety of O-quinols and P-quinols. It primarily found in FUNGI and is involved in LIGNIN degradation, pigment biosynthesis and detoxification of lignin-derived products. ( MSH )] (UMLS (CSP) C0064566) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 30. LaBID
- (UMLS (NCI) C0700844) =Organic Chemical; Pharmacologic Substance
| - 80. LACER OF CERVIX-POSTPART
- [ ] (UMLS (ICD9CM) C0157361) =Disease or Syndrome
|
- 31. labor
- [The repetitive uterine contraction during childbirth which is associated with the progressive dilation of the uterine cervix (CERVIX UTERI). Successful labor results in the expulsion of the FETUS and PLACENTA. Obstetric labor can be spontaneous or induced (LABOR, INDUCED). ( MSH )] (UMLS (CSP) C0022864) =Organism Function ;
| - 81. LACERAT OF CERVIX-DELIV
- [ ] (UMLS (ICD9CM) C0157358) =Injury or Poisoning
|
- 32. Labor and Delivery
- (UMLS (HL7) C1561959) =Intellectual Product =Admission Type;
| - 82. LACERAT OF CERVIX-UNSPEC
- [ ] (UMLS (ICD9CM) C0157359) =Disease or Syndrome
|
- 33. labor and delivery
- (UMLS (HL7) C1546400) =Idea or Concept =EncounterAdmissionSource;
| - 83. Laceration
- [Torn, ragged, mangled wounds. ( MSH )] (UMLS (NCI) C0043246) =Injury or Poisoning =trauma;
|
- 34. Labor and industries number
- (UMLS (HL7) C1549707) =Idea or Concept =Identifier type;
Practitioner ID number type | - 84. LACERATION OF EYE NOS
- [ ] (UMLS (ICD9CM) C0160470) =Injury or Poisoning
|
- 35. labor complication
- [medical problems associated with childbirth including cephalopelvic disproportion, hemorrhage, or fetal distress. ( CSP )] (UMLS (CSP) C0022865) =Disease or Syndrome ;
=Pregnancy Complication;
Pregnancy Disorder =abruptio placentae;
Dystocia;
Fetal Membranes, Premature Rupture;
Placenta Accreta;
Placenta Praevia;
ERDITZE ONDORENGO ODOLJARIO GARRANTZITSUA;
Uterine Rupture;
| - 85. Laceration of liver, major, with open wound into cavity
- [ ] (UMLS (ICD9CM) C0273182) =Injury or Poisoning
|
- 36. labor union
- [organization of workers formed for the purpose of serving the members' interests with respect to wages, status and working conditions. ( CSP )] (UMLS (CSP) C0022874) =Organization ;
=Job;
club | - 86. Laceration of liver, major, without mention of open wound into cavity
- [ ] (UMLS (ICD9CM) C0160396) =Injury or Poisoning
|
- 37. Laboratories
- [A room or building equipped for scientific experimentation, research, testing, or clinical studies of materials, fluids, or tissues obtained from patients. ( HL7V3.0 )] (UMLS (HL7) C1619828) =Intellectual Product ;
=NUCC Health Care Provider Taxonomy;
=Clinical Medical Laboratory;
Physiological Laboratory, (Independent Physiological Lab);
Dental Laboratory;
| - 87. Laceration of liver, minor, with open wound into cavity
- [ ] (UMLS (ICD9CM) C0160401) =Injury or Poisoning
|
- 38. Laboratories; Clinical Medical Laboratory
- [(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. ( HL7V3.0 )] (UMLS (HL7) C1551301) =Manufactured Object; Health Care Related Organization =HealthcareProviderTaxonomyHIPAA;
| - 88. Laceration of liver, minor, without mention of open wound into cavity
- [ ] (UMLS (ICD9CM) C0160394) =Injury or Poisoning
|
- 39. Laboratories; Dental Laboratory
- [A commercial laboratory specializing in the construction of dental appliances that conform to a dentist's specifications including the construction of dentures (complete or partial), orthodontic appliances, bridgework, crowns, and inlays. ( HL7V3.0 )] (UMLS (HL7) C1551302) =Manufactured Object; Health Care Related Organization =HealthcareProviderTaxonomyHIPAA;
| - 89. Laceration of liver, moderate, with open wound into cavity
- [ ] (UMLS (ICD9CM) C0160402) =Injury or Poisoning
|
- 40. Laboratories; Physiological Laboratory
- [A laboratory that operates independently of a hospital and physician's office to furnish physiological diagnostic services (e.g. EEG's , EKG's, scans, etc.). Facilities offering ONLY physiological services are not certified as independent laboratories. If an independent laboratory offers physiological services IN ADDITION to clinical laboratory services, they are surveyed only for compliance with the clinical laboratory regulations because there are no health and safety regulations for physiological services. ( HL7V3.0 )] (UMLS (HL7) C1551303) =Manufactured Object; Health Care Related Organization =HealthcareProviderTaxonomyHIPAA;
| - 90. Laceration of liver, moderate, without mention of open wound into cavity
- [ ] (UMLS (ICD9CM) C0273175) =Injury or Poisoning
|
- 41. Laboratory
- (UMLS (HL7) C1548427) =Idea or Concept =Referral type;
| - 91. Laceration of lung with open wound into thorax
- [ ] (UMLS (ICD9CM) C0160334) =Injury or Poisoning
|
- 42. Laboratory
- (UMLS (HL7) C1571737) =Intellectual Product; ;
=Diagnostic Service Section ID;
| - 92. Laceration of lung without open wound into thorax
- [ ] (UMLS (ICD9CM) C0160330) =Injury or Poisoning
|
- 43. Laboratory
- (UMLS (HL7) C1697786) =Intellectual Product =RoleCode;
| - 93. Laceration of spleen extending into parenchyma without mention of open wound into cavity
- [ ] (UMLS (ICD9CM) C0160410) =Injury or Poisoning
|
- 44. laboratory accident
- [ ] (UMLS (CSP) C0920566) =Injury or Poisoning
| - 94. Laceration of spleen extending into parenchyma, with open wound into cavity
- [ ] (UMLS (ICD9CM) C0160417) =Injury or Poisoning
|
- 45. laboratory accident/infection
- [accidentally acquired infection or injury in laboratory workers. ( CSP )] (UMLS (CSP) C0178726) =Injury or Poisoning ;
=infection;
occupational hazard | - 95. Laceration(s), liver
- (UMLS (NCI) C0347633) =Injury or Poisoning
|
- 46. Laboratory acknowledgment message (unsolicited)
- (UMLS (HL7) C1548058) =Idea or Concept =Message type;
| - 96. Laceration/cut
- (UMLS (ICPC) C0497374) (Laceration/cut; ZAURTZEA/EBAKI ZAURIA; Sar/snit; Scheurwond/snijwond; REPEAMA/VIILTO; Dechirure/Coupure/Laceration; Riss-/Schnittwunde der Haut; xetax o ptzia baor; szakitas/tepes/vagas; Lacerazione/taglio; SARSKADE/KUTT; Laceracao/ferida aberta; Laceraciones/heridas incisas; LACERATION/SKARSAR) =Injury or Poisoning =Symptoms and Complaints Component; Integument
|
- 47. Laboratory Animal
- [A grouping of those animals that are commonly used as subjects in laboratory research. ( NCI )] (UMLS (NCI) C0003064) =Animal ;
| - 97. Lacertilla
- [ ] (UMLS (CSP) C1656060) =Reptile
|
- 48. Laboratory Animal Science
- [The science and technology dealing with the procurement, breeding, care, health, and selection of animals used in biomedical research and testing. ( MSH )] (UMLS (NCI) C0022880) =Biomedical Occupation or Discipline ;
| - 98. LACK NORM PHYSIO DEV NOS
- [ ] (UMLS (ICD9CM) C0878706) Lack of normal physiological development, unspecified =Sign or Symptom
|
- 49. laboratory cat
- [ ] (UMLS (CSP) C0598068) =Mammal ;
| - 99. LACK OF ADEQUATE SLEEP
- [ ] (UMLS (ICD9CM) C1455980) =Finding
|
- 50. LABORATORY EXAMINATION
- [ ] (UMLS (ICD9CM) C0260877) =Finding
| - 100. LACK OF COORDINATION
- (UMLS (ICD9CM) C0520966) =Sign or Symptom
|
home
